Efficacy of tezepelumab in patients with severe asthma and persistent airflow obstruction
Background Persistent airflow obstruction (PAO) in patients with asthma can be difficult to treat. Tezepelumab blocks thymic stromal lymphopoietin, an epithelial cytokine implicated in asthma pathogenesis. This analysis evaluated the efficacy of tezepelumab in patients with severe, uncontrolled asth...
Saved in:
Main Authors: | Elliot Israel, Mario Castro, Christopher S. Ambrose, Jean-Pierre Llanos, Nestor A. Molfino, Nicole L. Martin, Sandhia S. Ponnarambil, Neil Martin |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2024-11-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/10/6/00164-2024.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tezepelumab for asthma with current or previous smoking habit: Case series
by: Yoshiro Kai, MD, PhD, et al.
Published: (2025-05-01) -
Airflow Obstruction in Young Adults in Canada
by: Manal Al-Hazmi, et al.
Published: (2007-01-01) -
Peripheral blood miRNAs are associated with airflow below threshold in children with asthma
by: Anshul Tiwari, et al.
Published: (2025-01-01) -
Association between erectile dysfunction and the severity of obstruction to airflow in patients with chronic obstructive pulmonary disease
by: María J. Pareja-Zabala, et al.
Published: (2023-10-01) -
Free DNA in Cystic Fibrosis Airway Fluids Correlates with Airflow Obstruction
by: Veronica Marcos, et al.
Published: (2015-01-01)